| scholarly article | Q13442814 |
| P50 | author | Ralph Weissleder | Q7288259 |
| Ching-Hsuan Tung | Q39184020 | ||
| Xandra O. Breakefield | Q63607934 | ||
| P2093 | author name string | Khalid Shah | |
| P2860 | cites work | Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 |
| The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis | Q27732868 | ||
| APO2 ligand: a novel lethal weapon against malignant glioma? | Q28272697 | ||
| Cell death: the significance of apoptosis | Q29617620 | ||
| Apoptosis control by death and decoy receptors | Q33597389 | ||
| Optical imaging of Renilla luciferase reporter gene expression in living mice | Q33897818 | ||
| Noninvasive real-time imaging of apoptosis | Q34429029 | ||
| Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis | Q40860890 | ||
| Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
| HSV-tk gene therapy for human renal cell carcinoma in nude mice | Q43703262 | ||
| Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy | Q44198636 | ||
| Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo | Q44611172 | ||
| Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome | Q45737646 | ||
| Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect | Q63865750 | ||
| Cell Death in Development | Q67531415 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 926-931 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. | |
| P478 | volume | 11 |
| Q92635715 | A Novel Dual Fluorochrome Near-Infrared Imaging Probe for Potential Alzheimer's Enzyme Biomarkers-BACE1 and Cathepsin D |
| Q34448294 | A biocompatible "split luciferin" reaction and its application for non-invasive bioluminescent imaging of protease activity in living animals |
| Q37331739 | A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice. |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q39638959 | Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth |
| Q37483966 | Applications of neural and mesenchymal stem cells in the treatment of gliomas |
| Q38420827 | Bioresponsive probes for molecular imaging: concepts and in vivo applications |
| Q37604204 | Brain cancer stem cells. |
| Q90054134 | Cell-specific image-guided transcriptomics identifies complex injuries caused by ischemic acute kidney injury in mice |
| Q37096959 | Cellular MRI and its role in stem cell therapy |
| Q31013320 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors |
| Q35891172 | Design of "smart" probes for optical imaging of apoptosis |
| Q27303746 | Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging |
| Q38090923 | Encapsulated stem cells for cancer therapy |
| Q36897379 | HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. |
| Q40882937 | Identification of mutant firefly luciferases that efficiently utilize aminoluciferins |
| Q34997790 | Imaging beta-galactosidase activity in vivo using sequential reporter-enzyme luminescence |
| Q36015054 | Imaging virus-associated cancer. |
| Q33926247 | In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates. |
| Q39630886 | In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. |
| Q34504430 | Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence |
| Q38063413 | Making the brain glow: in vivo bioluminescence imaging to study neurodegeneration |
| Q35902332 | Methods for gene transfer to the central nervous system |
| Q37710417 | Molecular Imaging of Proteases in Cancer |
| Q36512525 | Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors |
| Q37971309 | Neurotransplantation: lux et veritas, fiction or reality? |
| Q39754552 | Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin |
| Q38089835 | Optical molecular imaging in drug discovery and clinical development |
| Q33825333 | Preventing growth of brain tumors by creating a zone of resistance |
| Q41383246 | Real-time noninvasive imaging of fatty acid uptake in vivo |
| Q36324626 | Recent Advance of Biological Molecular Imaging Based on Lanthanide-Doped Upconversion-Luminescent Nanomaterials. |
| Q39856479 | Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer |
| Q35836079 | Small Molecule Active Site Directed Tools for Studying Human Caspases |
| Q37120161 | Stem and progenitor cell-mediated tumor selective gene therapy |
| Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
| Q36062517 | Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas |
| Q37873318 | Strategies for in vivo imaging of enzyme activity: an overview and recent advances |
| Q36642035 | Strategy for dual-analyte luciferin imaging: in vivo bioluminescence detection of hydrogen peroxide and caspase activity in a murine model of acute inflammation |
| Q34291312 | TRAIL in cancer therapy: present and future challenges |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q38867453 | The effect of AZD2171- or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model |
| Q39070809 | The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases |
| Q39285733 | Therapeutic application of multipotent stem cells |
| Q37122166 | Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare |
| Q35812718 | Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. |
| Q57346279 | Upconversion Nanoparticles for Bioimaging |
Search more.